Cargando…
94. Infectious Complications of Left Ventricular Assist Devices
BACKGROUND: Left ventricular assist devices (VAD) have significantly increased survival for patients with advanced heart failure. While advancements in devices during the past 10 years have improved thrombotic and bleeding complications, infection remains a significant cause of morbidity and mortali...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644914/ http://dx.doi.org/10.1093/ofid/ofab466.094 |
_version_ | 1784610196510736384 |
---|---|
author | Harris, Courtney Coakley, Lara Mehra, Mandeep R Mallidi, Hari R Baden, Lindsey R Woolley, Ann E |
author_facet | Harris, Courtney Coakley, Lara Mehra, Mandeep R Mallidi, Hari R Baden, Lindsey R Woolley, Ann E |
author_sort | Harris, Courtney |
collection | PubMed |
description | BACKGROUND: Left ventricular assist devices (VAD) have significantly increased survival for patients with advanced heart failure. While advancements in devices during the past 10 years have improved thrombotic and bleeding complications, infection remains a significant cause of morbidity and mortality. We assessed the incidence and risk factors of VAD infections at our institution. METHODS: A single center, retrospective study of patients who had VAD implanted between January 2007 and December 2020 was performed. Patients with concurrent right sided mechanical circulatory support devices were excluded. Patient demographics, clinical characteristics, labs, microbiology data, and antimicrobials were obtained from the electronic medical records. Clinical outcomes were adjudicated by 2 independent physicians. VAD infections were classified using the ISHLT 2011 guidelines. RESULTS: 241 patients had durable VAD implanted in this 14-year period, with a median time of 3 years follow-up. 134 (56%) patients had a clinically significant infection; 42 (31.3%) were VAD specific infections, 42 (31.3%) were VAD related, and 50 (37.4%) were non-VAD related. 95% of VAD specific infections were driveline site infections. 98% of patients with VAD related infections had a concurrent blood stream infection. Of the 50 non-VAD infections, 72% involved either a lower respiratory, urinary tract, or Clostridium difficile infection. Median time from VAD implantation to infection was 5 months. 44 (32.8%) had their first infection during the index hospitalization, of which 27 (61.4%) were non-VAD infections. 78 (58.2%) had one infection, compared with 38 (28.4%) who had two or more infections. 17 (12.7%) had recurrence of their initial infection and 6 (35%) occurred despite being on suppressive antibiotics. 48 of 134 (36%) infected patients were transplanted. 57 of 134 (42.5%) died compared to 33 of 107 (31%) without an infection. [Image: see text] CONCLUSION: More than half of VAD patients at our center during a 14-year time period had an infectious complication and higher mortality rate compared to those without an infectious complication. Further studies are needed to assess the immunologic risk factors for the increased risk of non-device associated infections in VAD patients. DISCLOSURES: Mandeep R. Mehra, MD, Abbott (Consultant)Baim Institute for Clinical Research (Consultant)FineHeart (Consultant)NupulseCV (Consultant) Ann E. Woolley, MD, MPH, COVAX (Consultant) |
format | Online Article Text |
id | pubmed-8644914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86449142021-12-06 94. Infectious Complications of Left Ventricular Assist Devices Harris, Courtney Coakley, Lara Mehra, Mandeep R Mallidi, Hari R Baden, Lindsey R Woolley, Ann E Open Forum Infect Dis Oral Abstracts BACKGROUND: Left ventricular assist devices (VAD) have significantly increased survival for patients with advanced heart failure. While advancements in devices during the past 10 years have improved thrombotic and bleeding complications, infection remains a significant cause of morbidity and mortality. We assessed the incidence and risk factors of VAD infections at our institution. METHODS: A single center, retrospective study of patients who had VAD implanted between January 2007 and December 2020 was performed. Patients with concurrent right sided mechanical circulatory support devices were excluded. Patient demographics, clinical characteristics, labs, microbiology data, and antimicrobials were obtained from the electronic medical records. Clinical outcomes were adjudicated by 2 independent physicians. VAD infections were classified using the ISHLT 2011 guidelines. RESULTS: 241 patients had durable VAD implanted in this 14-year period, with a median time of 3 years follow-up. 134 (56%) patients had a clinically significant infection; 42 (31.3%) were VAD specific infections, 42 (31.3%) were VAD related, and 50 (37.4%) were non-VAD related. 95% of VAD specific infections were driveline site infections. 98% of patients with VAD related infections had a concurrent blood stream infection. Of the 50 non-VAD infections, 72% involved either a lower respiratory, urinary tract, or Clostridium difficile infection. Median time from VAD implantation to infection was 5 months. 44 (32.8%) had their first infection during the index hospitalization, of which 27 (61.4%) were non-VAD infections. 78 (58.2%) had one infection, compared with 38 (28.4%) who had two or more infections. 17 (12.7%) had recurrence of their initial infection and 6 (35%) occurred despite being on suppressive antibiotics. 48 of 134 (36%) infected patients were transplanted. 57 of 134 (42.5%) died compared to 33 of 107 (31%) without an infection. [Image: see text] CONCLUSION: More than half of VAD patients at our center during a 14-year time period had an infectious complication and higher mortality rate compared to those without an infectious complication. Further studies are needed to assess the immunologic risk factors for the increased risk of non-device associated infections in VAD patients. DISCLOSURES: Mandeep R. Mehra, MD, Abbott (Consultant)Baim Institute for Clinical Research (Consultant)FineHeart (Consultant)NupulseCV (Consultant) Ann E. Woolley, MD, MPH, COVAX (Consultant) Oxford University Press 2021-12-04 /pmc/articles/PMC8644914/ http://dx.doi.org/10.1093/ofid/ofab466.094 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Abstracts Harris, Courtney Coakley, Lara Mehra, Mandeep R Mallidi, Hari R Baden, Lindsey R Woolley, Ann E 94. Infectious Complications of Left Ventricular Assist Devices |
title | 94. Infectious Complications of Left Ventricular Assist Devices |
title_full | 94. Infectious Complications of Left Ventricular Assist Devices |
title_fullStr | 94. Infectious Complications of Left Ventricular Assist Devices |
title_full_unstemmed | 94. Infectious Complications of Left Ventricular Assist Devices |
title_short | 94. Infectious Complications of Left Ventricular Assist Devices |
title_sort | 94. infectious complications of left ventricular assist devices |
topic | Oral Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644914/ http://dx.doi.org/10.1093/ofid/ofab466.094 |
work_keys_str_mv | AT harriscourtney 94infectiouscomplicationsofleftventricularassistdevices AT coakleylara 94infectiouscomplicationsofleftventricularassistdevices AT mehramandeepr 94infectiouscomplicationsofleftventricularassistdevices AT mallidiharir 94infectiouscomplicationsofleftventricularassistdevices AT badenlindseyr 94infectiouscomplicationsofleftventricularassistdevices AT woolleyanne 94infectiouscomplicationsofleftventricularassistdevices |